As the application duration increased, a fluctuation in mTOR activity was observed in MM cancer stem cell lines, while LC3 activity steadily increased, with a greater increase observed in the MM cancer cell line after 10 min of application. The gene discussed is MAP1LC3A; the disease is Miyoshi myopathy.